These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9464792)

  • 41. Crystal structure of the human p58 killer cell inhibitory receptor (KIR2DL3) specific for HLA-Cw3-related MHC class I.
    Maenaka K; Juji T; Stuart DI; Jones EY
    Structure; 1999 Apr; 7(4):391-8. PubMed ID: 10196125
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diversity of the repertoire of p58 killer cell inhibitory receptors in a single individual.
    Chwae YJ; Cho SE; Kim SJ; Kim J
    Immunol Lett; 1999 Jun; 68(2-3):267-74. PubMed ID: 10424431
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The binding site of NK receptors on HLA-C molecules.
    Mandelboim O; Reyburn HT; Sheu EG; Vales-Gomez M; Davis DM; Pazmany L; Strominger JL
    Immunity; 1997 Mar; 6(3):341-50. PubMed ID: 9075934
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Recruitment of tyrosine phosphatase HCP by the killer cell inhibitor receptor.
    Burshtyn DN; Scharenberg AM; Wagtmann N; Rajagopalan S; Berrada K; Yi T; Kinet JP; Long EO
    Immunity; 1996 Jan; 4(1):77-85. PubMed ID: 8574854
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Physical and functional independency of p70 and p58 natural killer (NK) cell receptors for HLA class I: their role in the definition of different groups of alloreactive NK cell clones.
    Vitale M; Sivori S; Pende D; Augugliaro R; Di Donato C; Amoroso A; Malnati M; Bottino C; Moretta L; Moretta A
    Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1453-7. PubMed ID: 8643653
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Definition of polymorphic residues on killer Ig-like receptor proteins which contribute to the HLA-C binding site.
    Richardson J; Reyburn HT; Luque I; Valés-Gómez M; Strominger JL
    Eur J Immunol; 2000 May; 30(5):1480-5. PubMed ID: 10820396
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Coexpression of two functionally independent p58 inhibitory receptors in human natural killer cell clones results in the inability to kill all normal allogeneic target cells.
    Vitale M; Sivori S; Pende D; Moretta L; Moretta A
    Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3536-40. PubMed ID: 7724594
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Amino acid substitutions can influence the natural killer (NK)-mediated recognition of HLA-C molecules. Role of serine-77 and lysine-80 in the target cell protection from lysis mediated by "group 2" or "group 1" NK clones.
    Biassoni R; Falco M; Cambiaggi A; Costa P; Verdiani S; Pende D; Conte R; Di Donato C; Parham P; Moretta L
    J Exp Med; 1995 Aug; 182(2):605-9. PubMed ID: 7629517
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains.
    Wagtmann N; Biassoni R; Cantoni C; Verdiani S; Malnati MS; Vitale M; Bottino C; Moretta L; Moretta A; Long EO
    Immunity; 1995 May; 2(5):439-49. PubMed ID: 7749980
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Structure of human histocompatibility leukocyte antigen (HLA)-Cw4, a ligand for the KIR2D natural killer cell inhibitory receptor.
    Fan QR; Wiley DC
    J Exp Med; 1999 Jul; 190(1):113-23. PubMed ID: 10429675
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A single polymorphism disrupts the killer Ig-like receptor 2DL2/2DL3 D1 domain.
    VandenBussche CJ; Dakshanamurthy S; Posch PE; Hurley CK
    J Immunol; 2006 Oct; 177(8):5347-57. PubMed ID: 17015720
    [TBL] [Abstract][Full Text] [Related]  

  • 52. KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A*11 while diminishing avidity for HLA-C.
    Graef T; Moesta AK; Norman PJ; Abi-Rached L; Vago L; Older Aguilar AM; Gleimer M; Hammond JA; Guethlein LA; Bushnell DA; Robinson PJ; Parham P
    J Exp Med; 2009 Oct; 206(11):2557-72. PubMed ID: 19858347
    [TBL] [Abstract][Full Text] [Related]  

  • 53. P49, a putative HLA-G1 specific inhibitory NK receptor belonging to the immunoglobulin Superfamily.
    Cantoni C; Falco M; Pessino A; Moretta A; Moretta L; Biassoni R
    J Reprod Immunol; 1999 Jul; 43(2):157-65. PubMed ID: 10479051
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Crystallization and preliminary diffraction studies of the extracellular region of human p58 killer cell inhibitory receptor (KIR2).
    Maenaka K; Juji T; Tadokoro K; Harlos K; Stuart DI; Jones EY
    Acta Crystallogr D Biol Crystallogr; 1998 May; 54(Pt 3):433-5. PubMed ID: 9761919
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Structure of a human natural killer cell inhibitory receptor.
    Fan QR; Mosyak L; Garboczi DN; Winter CC; Wagtmann N; Long EO; Wiley DC
    Transplant Proc; 1999 Jun; 31(4):1871-2. PubMed ID: 10371978
    [No Abstract]   [Full Text] [Related]  

  • 56. Killer cell inhibitory receptors specific for HLA-C and HLA-B identified by direct binding and by functional transfer.
    Wagtmann N; Rajagopalan S; Winter CC; Peruzzi M; Long EO
    Immunity; 1995 Dec; 3(6):801-9. PubMed ID: 8777725
    [No Abstract]   [Full Text] [Related]  

  • 57. [Effect of activation of cellular immunity on p58+ cells expressing killer-cell-inhibitory receptor cells].
    Pang XH; Pang RQ; Guo KY; Song JG; Li JQ; Zhang YJ; Yang XF
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Feb; 11(1):70-3. PubMed ID: 12667294
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The role and novel use of natural killer cells in graft-versus-leukemia reactions after allogeneic transplantation.
    Hadjis AD; McCurdy SR
    Front Immunol; 2024; 15():1358668. PubMed ID: 38817602
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Innate receptors modulating adaptive T cell responses: KIR-HLA interactions and T cell-mediated control of chronic viral infections.
    Mora-Bitria L; Asquith B
    Immunogenetics; 2023 Jun; 75(3):269-282. PubMed ID: 36719466
    [TBL] [Abstract][Full Text] [Related]  

  • 60. KIR-HLA gene diversities and susceptibility to lung cancer.
    Hematian Larki M; Ashouri E; Barani S; Ghayumi SMA; Ghaderi A; Rajalingam R
    Sci Rep; 2022 Oct; 12(1):17237. PubMed ID: 36241658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.